<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ugekommentar - Regnskaber fra Genmab og Ambu]]></title><description><![CDATA[<p dir="auto">Der er kommet flere regnskaber, og i denne uge omtaler Helge Larsen Vestas, Genmab, Bavarian, Ambu, Tesla og Teva.</p>
<p dir="auto">OBS: Der er Q&amp;A med Jan van de Winkel, CEO, Genmab, fredag (Black Friday) den 26. november kl. 14.30-15.15.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/85Z9rxtuFRA" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/443296/ugekommentar-regnskaber-fra-genmab-og-ambu</link><generator>RSS for Node</generator><lastBuildDate>Fri, 03 Jul 2026 16:50:33 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/443296.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 11 Nov 2021 12:47:33 GMT</pubDate><ttl>60</ttl></channel></rss>